Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.4 |
mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
mRNA | StemRegenin 1 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.026 | 0.4 |
mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
mRNA | ML312 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.4 |
mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |